Literature DB >> 21275377

Time-course changes in potential biomarkers detected using a metabonomic approach in Walker 256 tumor-bearing rats.

Guoqing Shen1, Yanhua Chen, Jianghao Sun, Ruiping Zhang, Yi Zhang, Jiuming He, Yaping Tian, Yongmei Song, Xiaoguang Chen, Zeper Abliz.   

Abstract

A metabonomic approach based on complementary hydrophilic interaction chromatography and reversed-phase liquid chromatography combined with tandem mass spectrometry and time-course analysis of metabolites was implemented to find more reliable potential biomarkers in urine of Walker 256 tumor-bearing rats. A major challenge in metabonomics is distinguishing reliable biomarkers that are closely associated with the genesis and progression of diseases from those that are unrelated but altered significantly. In this study, these biomarkers were selected according to the change trends of discriminating metabolites during the genesis and progression of cancer. Seven consecutive batches of urine samples from preinoculation to 16 days after were collected and analyzed. Multivariate analysis revealed 87 discriminating metabolites. Time-course analysis of discriminating metabolites was used to select more reliable biomarkers with regular and reasonable change trends. Finally, 47 were found and 15 were identified including 12 carnitine derivatives, 2 amino acid derivatives, 1 nucleoside. On the basis of time-course behaviors of these potential biomarkers, we hypothesize such disruption might result from elevated cell proliferation, reduced β-oxidation of fatty acids, and poor renal tubular reabsorption. These studies demonstrate that this method can help to find more reliable potential biomarkers and provide valuable biochemical insights into metabolic alterations in tumor-bearing biosystems.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21275377     DOI: 10.1021/pr101198q

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  7 in total

1.  The Harbin Cohort Study on Diet, Nutrition and Chronic Non-communicable Diseases: study design and baseline characteristics.

Authors:  Lixin Na; Xiaoyan Wu; Rennan Feng; Jie Li; Tianshu Han; Liqun Lin; Li Lan; Chao Yang; Ying Li; Changhao Sun
Journal:  PLoS One       Date:  2015-04-09       Impact factor: 3.240

Review 2.  Chinese Herbs Interfering with Cancer Reprogramming Metabolism.

Authors:  Zhangfeng Zhong; William W Qiang; Wen Tan; Haotian Zhang; Shengpeng Wang; Chunming Wang; Wenan Qiang; Yitao Wang
Journal:  Evid Based Complement Alternat Med       Date:  2016-05-05       Impact factor: 2.629

3.  Leucine-rich diet alters the 1H-NMR based metabolomic profile without changing the Walker-256 tumour mass in rats.

Authors:  Laís Rosa Viana; Rafael Canevarolo; Anna Caroline Perina Luiz; Raquel Frias Soares; Camila Lubaczeuski; Ana Carolina de Mattos Zeri; Maria Cristina Cintra Gomes-Marcondes
Journal:  BMC Cancer       Date:  2016-10-03       Impact factor: 4.430

4.  Chemical Isotope Labeling LC-MS for Monitoring Disease Progression and Treatment in Animal Models: Plasma Metabolomics Study of Osteoarthritis Rat Model.

Authors:  Deying Chen; Xiaoling Su; Nan Wang; Yunong Li; Hua Yin; Liang Li; Lanjuan Li
Journal:  Sci Rep       Date:  2017-01-16       Impact factor: 4.379

5.  Calcium-deficiency assessment and biomarker identification by an integrated urinary metabonomics analysis.

Authors:  Maoqing Wang; Xue Yang; Fan Wang; Ran Li; Hua Ning; Lixin Na; Yifan Huang; Yue Song; Liyan Liu; Hongzhi Pan; Qiuju Zhang; Lijun Fan; Ying Li; Changhao Sun
Journal:  BMC Med       Date:  2013-03-28       Impact factor: 8.775

6.  In situ biomarker discovery and label-free molecular histopathological diagnosis of lung cancer by ambient mass spectrometry imaging.

Authors:  Tiegang Li; Jiuming He; Xinxin Mao; Ying Bi; Zhigang Luo; Chengan Guo; Fei Tang; Xin Xu; Xiaohao Wang; Mingrong Wang; Jie Chen; Zeper Abliz
Journal:  Sci Rep       Date:  2015-09-25       Impact factor: 4.379

7.  Dynamic changes of urine proteome in a Walker 256 tumor-bearing rat model.

Authors:  Jianqiang Wu; Zhengguang Guo; Youhe Gao
Journal:  Cancer Med       Date:  2017-10-04       Impact factor: 4.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.